10003859 J Clin Psychiatry / Document Archive

Psychiatrist.com Home    Keyword Search

Close [X]

Search Our Sites

Enter search terms below (keywords, titles, authors, or subjects). Then select a category to search and press the Search button. All words are assumed to be required. To search for an exact phrase, put it in quotes. To exclude a term, precede it with a minus sign (-).

Keyword search:

Choose a category:

Choosing the appropriate category will greatly improve your chances of finding the best match.

All files at our sites: J Clin Psychiatry, Primary Care Companion, CME Institute, and MedFair

Search materials from our journals:

Abstracts from The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements

PDFs of the full text of The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements (Net Society Platinum [paid subscribers])

PDFs of the full text of The Primary Care Companion to The Journal of Clinical Psychiatry, 1999–present

Search CME offerings:

CME Institute, including CME from journals , supplements, and Web activities for instant CME credit (Net Society Gold [registered users]); also includes information about our CME program

CME activities from regular issues of The Journal of Clinical Psychiatry (Net Society Gold [registered users])

CME Supplements from The Journal of Clinical Psychiatry (Net Society Gold [registered users])


The article you requested is

Serotonin Transporter Gene Status and Electroconvulsive Therapy Outcomes: A Retrospective Analysis of 83 Patients

J Clin Psychiatry 2009;70(1):92-94
Copyright 2008 Physicians Postgraduate Press, Inc.

To view this item, select one of the options below.

    1. Purchase this PDF for $40
      If you are not a paid subscriber, you may purchase the PDF.
      (You'll need the free Adobe Acrobat Reader.)
    2. Subscribe
      Receive immediate full-text access to JCP. You can subscribe to JCP print + online for $166 individual.
      JCP's 75th AnniversaryCelebrate!
      Celebrate JCP's 75th Anniversary with a special online-only subscription price of $75.
    1. Activate
      If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
    2. Sign in
      As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
  1. Did you forget your password?

Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email


Background: The length of the promoter polymorphism of the serotonin transporter gene has been shown to have an impact on response to some selective serotonin reuptake inhibitor antidepressants. Carrier status for the long allele has been associated with a better response to serotonin reuptake inhibitor antidepressant medications in most studies.

Method: We retrospectively studied whether the allelic state was also associated with differential response to electroconvulsive therapy (ECT). Eighty-three ECT patients treated for unipolar or bipolar depression (based upon the treating psychiatrist's DSM-IV diagnosis) between July 2006 and September 2007 had allelic status testing at our facility. We determined whether serotonin transporter gene allelic status was associated with several aspects of ECT treatment, such as seizure length/threshold, number of treatments in a series, and depression scale ratings.

Results: We found no significant associations.

Conclusion: We conclude that currently available serotonin transporter gene long/short promoter polymorphism allelic status determination should not be used to guide clinical decisions about ECT.